Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced new clinical data ...
Alnylam announced the FDA approval of its supplemental new drug application for vutrisiran, an RNA interfering small molecule ...
After he suffered from a stroke and congestive heart failure in 2013, Randy Travis lost the ability to speak — or sing ...
Despite growing competition in the transthyretin amyloid cardiomyopathy (ATTR-CM) field, Alnylam is hoping its RNA interference approach can set it apart from its peers. | Despite growing competition ...
Interactive Tool Harnesses Real-World Data to Visualize Burden of Disease in HCM and Advance Equitable Access to CareSOUTH SAN FRANCISCO, Calif., ...
Cardiomyopathy is an umbrella term used to describe difficulties with your heart being able to pump blood. There are different subtypes of this condition, including hypertrophic cardiomyopathy (HCM).
American Heart Month may be over, but experts still want to bring awareness to a condition that many people may have without ...
Danon disease is a rare but serious cardiomyopathy that drastically reduces life expectancy. Male patients infrequently live ...
An acute necrotising myopathy is a distinct form of uncommon muscle disease characterised by the rapid advancement of ...
A 12-week supervised high-intensity exercise programme was feasible for patients with hypertrophic cardiomyopathy (HCM), leading to potential improvements in cardiorespiratory fitness ...
A statement from Cork City read: ‘It is with a heavy heart that we today confirm the retirement of young 16 year old defender ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results